Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9291 |
High Similarity |
NPD7266 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8232 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8193 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8171 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8084 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7937 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD1613 |
Approved |
0.773 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7677 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7674 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7654 |
Intermediate Similarity |
NPD37 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD1934 |
Approved |
0.74 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD228 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7099 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7068 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD1358 |
Approved |
0.702 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD1933 |
Approved |
0.6994 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6988 |
Remote Similarity |
NPD3687 |
Approved |
0.6988 |
Remote Similarity |
NPD3686 |
Approved |
0.6982 |
Remote Similarity |
NPD7819 |
Suspended |
0.6982 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6964 |
Remote Similarity |
NPD6386 |
Approved |
0.6964 |
Remote Similarity |
NPD6385 |
Approved |
0.6962 |
Remote Similarity |
NPD6653 |
Approved |
0.6959 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD1511 |
Approved |
0.6948 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD9494 |
Approved |
0.6944 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6937 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6933 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6928 |
Remote Similarity |
NPD5403 |
Approved |
0.6923 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6841 |
Approved |
0.6923 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6842 |
Approved |
0.6923 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4536 |
Approved |
0.6918 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4538 |
Approved |
0.6914 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3060 |
Approved |
0.6907 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6897 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6895 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6894 |
Remote Similarity |
NPD5763 |
Approved |
0.6894 |
Remote Similarity |
NPD5762 |
Approved |
0.6887 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD5494 |
Approved |
0.6872 |
Remote Similarity |
NPD7038 |
Approved |
0.6872 |
Remote Similarity |
NPD7039 |
Approved |
0.6871 |
Remote Similarity |
NPD7157 |
Approved |
0.6871 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6867 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD1512 |
Approved |
0.6848 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6845 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD3134 |
Approved |
0.6824 |
Remote Similarity |
NPD6801 |
Discontinued |
0.681 |
Remote Similarity |
NPD4237 |
Approved |
0.681 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6807 |
Remote Similarity |
NPD5401 |
Approved |
0.6807 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD7697 |
Approved |
0.6806 |
Remote Similarity |
NPD7698 |
Approved |
0.6806 |
Remote Similarity |
NPD3021 |
Approved |
0.6806 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6806 |
Remote Similarity |
NPD3022 |
Approved |
0.6805 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD447 |
Suspended |
0.679 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD5535 |
Approved |
0.6776 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6771 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6771 |
Remote Similarity |
NPD8319 |
Approved |
0.677 |
Remote Similarity |
NPD5588 |
Approved |
0.677 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.677 |
Remote Similarity |
NPD4108 |
Discontinued |
0.677 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6769 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD7874 |
Approved |
0.6768 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD3750 |
Approved |
0.6768 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7411 |
Suspended |
0.6755 |
Remote Similarity |
NPD4626 |
Approved |
0.6755 |
Remote Similarity |
NPD5126 |
Approved |
0.6755 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6754 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD3225 |
Approved |
0.6753 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD8651 |
Approved |
0.6747 |
Remote Similarity |
NPD6799 |
Approved |
0.6744 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD5353 |
Approved |
0.6737 |
Remote Similarity |
NPD6776 |
Approved |
0.6737 |
Remote Similarity |
NPD6777 |
Approved |
0.6737 |
Remote Similarity |
NPD6778 |
Approved |
0.6737 |
Remote Similarity |
NPD6779 |
Approved |
0.6737 |
Remote Similarity |
NPD6782 |
Approved |
0.6737 |
Remote Similarity |
NPD6780 |
Approved |
0.6737 |
Remote Similarity |
NPD6781 |
Approved |
0.6736 |
Remote Similarity |
NPD2684 |
Approved |
0.6733 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.673 |
Remote Similarity |
NPD4140 |
Approved |
0.6723 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6707 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6689 |
Remote Similarity |
NPD5691 |
Approved |
0.6687 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6687 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6685
|
Remote Similarity |
NPD8150 |
Discontinued |